About
Mynvax is a clinical stage vaccine biotechnology company that develops novel, thermostable recombinant vaccines targeting respiratory viral infections, including COVID-19, with a focus on accessibility for low and lower-middle-income countries.
Explore Mynvax's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.